Patents Assigned to Monsanto Company
  • Patent number: 6698668
    Abstract: A mobile shielded plot sprayer including a wind shield having a side wall that defines an enclosed area, and a movable atomizer within the enclosed area. A track assembly is located within the enclosed area and supported on the windshield. The atomizer is part of a spray assembly mounted on the track assembly and is movable thereon in at least one horizontal direction relative to the wind shield. A reservoir integral with the spray assembly and adapted to hold a liquid spray composition is operatively connected to the atomizer to supply the spray composition thereto.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: March 2, 2004
    Assignee: Monsanto Company
    Inventor: Sammy J. Stehling
  • Publication number: 20040010143
    Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
    Type: Application
    Filed: February 20, 2003
    Publication date: January 15, 2004
    Applicants: G.D. Searle & Co., Pharmacia Corporation (Monsanto Company)
    Inventors: Deborah E. Bertenshaw, Daniel P. Getman, Robert M. Heintz, John J. Talley, Kathryn L. Reed, Robert Alan Chrusciel, Michael Clare
  • Patent number: 6673241
    Abstract: The present invention is directed to a foldable, self-floating cover system for a body of water. This invention is also directed to a method of using this cover on a body of water, and particularly on a sewage lagoon to reduce the emission of offensive odors and/or gases.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: January 6, 2004
    Assignee: Monsanto Company
    Inventors: Albert E. Tung, Brent A. Roberts
  • Publication number: 20030236414
    Abstract: The invention includes selected novel optically active &agr;-amino ketones which either are themselves useful or are intermediates for the preparation of known ketomethylene pseudopeptides useful as antibiotics, antibiotic enhancers, or enzyme inhibitors. Further, the present invention provides a method for dehydrogenation/asymmetrical hydrogenation to obtain essentially pure antipodes of ketomethylene pseudopeptides having two chiral centers.
    Type: Application
    Filed: February 14, 2003
    Publication date: December 25, 2003
    Applicant: Monsanto Company
    Inventor: John J. Talley
  • Publication number: 20030195227
    Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Application
    Filed: September 18, 2002
    Publication date: October 16, 2003
    Applicant: Monsanto Company
    Inventors: John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, Kathryn L. Reed, Ko-Chung Lin, John Nicholas Freskos, Michael Clare, Donald Joseph Rogier, Robert M. Heintz, Michael L. Vazquez, Richard A. Mueller
  • Patent number: 6617496
    Abstract: A strategy for effecting virus resistance in plants causes the transcription in the plant cells of negative RNA strands which are substantially complementary to a target RNA strand. The target RNA strand can be an mRNA transcript created in gene expression, a viral RNA, or other RNA present in the plant cells. The negative RNA strand is complementary to at least a portion of the target RNA strand to inhibit its activity in vivo.
    Type: Grant
    Filed: October 16, 1985
    Date of Patent: September 9, 2003
    Assignee: Monsanto Company
    Inventors: Francis P. McCormick, Kenneth A. Barton, William F. Swain
  • Patent number: 6603061
    Abstract: The present invention relates to a novel transformation system for generating transformed plants with lower copy inserts and improved transformation efficiency. In particular, the invention relates to the use of Agrobacterium growth inhibiting agents during the Agrobacterium-mediated transformation process that suppress Agrobacterium growth and reduce T-DNA transfer to the target plant genome.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: August 5, 2003
    Assignee: Monsanto Company
    Inventors: Charles L Armstrong, Jyoti R Rout
  • Publication number: 20030144396
    Abstract: Polyvinyl butyral resin and sheet having a hydroxyl content less than 19.5, preferably about 17 to 19 weight %, calculated as polyvinyl alcohol, plasticized with a compatible amount of triethylene glycol di-2-ethylhexanoate.
    Type: Application
    Filed: January 22, 2003
    Publication date: July 31, 2003
    Applicant: Monsanto Company
    Inventors: John J. D'Errico, Berkeley A. Jemmott, Mary S. Krach, James R. Moran
  • Patent number: 6600088
    Abstract: Improved methods for the identification of transgenic plants containing NPTII protein are disclosed. Application of organosilicone surfactant in combination with kanamycin and/or paromomycin facilitates the identification of plants containing NPTII protein.
    Type: Grant
    Filed: February 24, 2000
    Date of Patent: July 29, 2003
    Assignee: Monsanto Company
    Inventors: Arlene R. Howe, Paul C. C. Feng
  • Patent number: 6569809
    Abstract: A concentrate package-mix composition comprising a water-soluble pesticide or plant growth regulator, for example a salt of the herbicide glyphosate, and a solid water-insoluble pesticide or plant growth regulator, for example the herbicide flumioxazin, is provided. The water-soluble pesticide or plant growth regulator is dissolved in a continuous aqueous phase of the composition and solid particles of the water-insoluble pesticide or plant growth regulator are suspended in the aqueous phase. These solid particles, individually or plurally, are intimately surrounded by a barrier layer, which comprises either one or both of a water-immiscible organic solvent or an emulsifying agent that has a hydrophile-lipophile balance (HLB) not greater than about 15. Optionally the composition further comprises a viscosity modifying agent, such as colloidal hydrophilic silica, dispersed in the aqueous phase.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: May 27, 2003
    Assignee: Monsanto Company
    Inventors: Tatsuo Sato, Masus Kuchikata
  • Patent number: 6566134
    Abstract: The utility of soybeans having a composition of greater than 40% of the protein as beta-conglycinin and less than 10% of the protein as glycinin for making highly functional high beta-conglycinin compositions was discovered. The discovered ingredients are useful for mimicking the texturizing properties of casein while also maintaining or improving physiological benefits of soy protein ingredients (e.g., cholesterol and triglyceride lowering properties). The high stability of the high beta-conglycinin compositions against protein—protein aggregation reactions is valuable for creating good tasting beverages and beverage mixes. Cheese with good spreadability, gloss and smoothness was made using an enzyme-modified version of the new ingredient composition. Cheese with good firmness and meltability was also created using a different enzyme-treatment. High beta-conglycinin compositions were found to demonstrate excellent emulsifying and gelling properties in the pH region (5.5-6.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: May 20, 2003
    Assignee: Monsanto Company
    Inventor: Neal A. Bringe
  • Patent number: 6559212
    Abstract: Polyvinyl butyral resin and sheet having a hydroxyl content less than 19.5, preferably about 17 to 19 weight %, calculated as polyvinyl alcohol, plasticized with a compatible amount of triethylene glycol di-2-ethylhexanoate.
    Type: Grant
    Filed: December 29, 1995
    Date of Patent: May 6, 2003
    Assignee: Monsanto Company
    Inventors: John J. D'Errico, Berkeley A. Jemmott, Mary S. Krach, James R. Moran
  • Patent number: 6555706
    Abstract: This invention is directed to a process for making an iminodiacetic acid compound from a monoethanolamine substrate having the formula: wherein R1 is hydrogen, hydrocarbyl, or substituted hydrocarbyl. The process includes a series of reactions comprising a cyanomethylation, a hydrolysis and a dehydrogenation with the hydrolysis and dehydrogenation steps being carried out either sequentially or concurrently. In a particular embodiment, the iminodiacetic acid produced is disodium iminodiacetic acid and the monoethanolamine substrate used is 2-aminoethanol.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: April 29, 2003
    Assignee: Monsanto Company
    Inventors: Howard C. Berk, Thaddeus S. Franczyk, II, Robert B. Weisenfeld, David A. Morgenstern, Juan P. Arhancet, William L. Moench, James C. Peterson
  • Patent number: 6552203
    Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: April 22, 2003
    Assignee: Monsanto Company
    Inventors: Deborah E. Bertenshaw, Daniel Getman, Robert M. Heintz, John J. Talley, Kathryn L. Reed, Robert Alan Chrusciel, Michael Clare
  • Patent number: 6541654
    Abstract: The invention includes selected novel optically active &agr;-amino ketones which either are themselves useful or are intermediates for the preparation of known ketomethylene pseudopeptides useful as antibiotics, antibiotic enhancers, or enzyme inhibitors. Further, the present invention provides a method for dehydrogenation/asymmetrical hydrogenation to obtain essentially pure antipodes of ketomethylene pseudopeptides having two chiral centers.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: April 1, 2003
    Assignee: Monsanto Company
    Inventor: John J. Talley
  • Patent number: 6506759
    Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: January 14, 2003
    Assignee: Monsanto Company
    Inventors: John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, Kathryn L. Reed, Ko-Chung Lin, John Nicholas Freskos, Michael Clare, Donald Joseph Rogier, Jr., Robert M. Heintz, Michael L. Vazquez, Richard A. Mueller
  • Patent number: 6505146
    Abstract: The invention provides a method for analyzing spatial variations in field and crop performance. The method allows analysis of the field and crop performance as a function of various treatment and/or environmental conditions. This method is an advance over the prior art in that it allows better defined, more accurate comparisons of adjacent test areas, eliminating the need for extrapolation of data and avoiding inaccuracies therefrom. Also, the more accurate comparisons allow better characterization of effects due to the environment, such as those caused by genotype by environment (G×E) interaction. The more accurately defined comparison units also lead to improved analysis when comparing to other data layers for non-spatial analysis. The invention also provides a system for carrying out this method. The system preferably includes a device for inputting spatially-referenced data, a memory, an output device, and a processor. The output data may be represented spatially or non-spatially.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: January 7, 2003
    Assignee: Monsanto Company
    Inventor: Tracy M. Blackmer
  • Publication number: 20030005491
    Abstract: The present invention is in the field of soybean genetics. More specifically, the invention relates to nucleic acid molecules from regions the soybean genome, which are associated with soybean cyst nematode resistance. The invention also relates to proteins encoded by such nucleic acid molecules as well as antibodies capable of recognizing these proteins. The invention also relates to nucleic acid markers from regions the soybean genome, which are associated with soybean cyst nematode resistance. Moreover, the invention relates to uses of such molecules, including, transforming soybean cyst nematode resistant soybean with constructs containing nucleic acid molecules from regions the soybean genome, which are associated with soybean cyst nematode resistance. Furthermore, the invention relates to the use of such molecules in a plant breeding program.
    Type: Application
    Filed: January 5, 2001
    Publication date: January 2, 2003
    Applicant: Monsanto Company
    Inventors: Brian M. Hauge, Ming Li Wang, Jeremy David Parsons, Laurence David Parnell
  • Publication number: 20020192305
    Abstract: The present invention provides a method for inhibiting the activity of cyclooxygenase-2 and other proinflammatory factors in a mammal. The method comprises administering to the mammal, a therapeutically effective or prophylactically effective amount of an organic extract of Atractylodes lancea. The inhibitory effect of the organic extract of this invention on cyclooxygenase-2 activity is substantially greater than the inhibitory effect of the organic extract on cyclooxygenase-1 activity. The present invention also provides a method for treating a mammal having, or at risk for developing, a condition which is benefited by the inhibition of cyclooxygenase-2 or other proinflammatory factors. The method comprises administering to the mammal a therapeutically effective or prophylactically effective amount of the organic extract of Atractylodes lancea.
    Type: Application
    Filed: June 13, 2002
    Publication date: December 19, 2002
    Applicant: Monsanto Company
    Inventors: David G. Corley, Mark Obukowicz
  • Patent number: 6485747
    Abstract: A tablet coating useful for coating an active selected from the group consisting of aspirin, ibuprofen, naproxin sodium, acetaminophen, celecoxib, sildenafil citrate, alendronate sodium, an analgesic in combination with one or more of an antitussive, antihistamine, decongestant and expectorant, oxaprozin, comprising gellan gum along with a process which comprises admixing gellan gum and water under effective shear conditions to prepare an aqueous gellan gum coating composition thereof whereby the aqueous gellan gum coating composition is applied in an adherent fashion to a placebo or a tablet containing an active to form a gellan gum coated placebo or gellan gum coated active.
    Type: Grant
    Filed: October 11, 1999
    Date of Patent: November 26, 2002
    Assignee: Monsanto Company
    Inventors: John Flanagan, Terry L. Smith, Aaron Barkley, Richard E. Nicholson, Timothy Patrick Callahan